Key result
Transvenous lead extraction proves feasible in a patient with persistent left superior vena cava.
Why the study?
The increasing use of cardiac implantable electronic devices has led to more transvenous lead extraction procedures, which have become more challenging in elderly patients with complex device systems.
Case Report (n=1)
Describes the procedure of transvenous lead extraction in a patient with the congenital anomaly of a persistent left superior vena cava.
Answers are grounded in this paper and cite their sources.
Informs lead extraction planning for rare PLSVC anatomy; leaves open need for systematic safety data before wider adoption.
Transvenous lead extraction is the gold standard for lead removal. Within recent years the number of lead removal procedures has constantly increased secondary to the increasing use of cardiac implantable electronic devices (pacemakers and implantable cardioverter-defibrillators).1–3 With increasing prevalence, extraction techniques have greatly evolved but have also become increasingly challenging in a progressively elderly patient population with increasingly complex device systems. The chief indication for lead removal remains device infection, a class I indication for complete system extraction.
No takes yet. Share an insight, caveat, or question.
Trenson et al. (2020) conducted a case report in Persistent left superior vena cava requiring lead extraction (n=1). Transvenous lead extraction was evaluated. Transvenous lead extraction was described in a patient with a persistent left superior vena cava.
Synapse has enriched 10 related papers. Consider them for comparative context: